Prucalopride: a new drug for the treatment of chronic constipation

5-HT4 receptor agonists: similar but not the same

(2010) J. H. De Maeyer et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Selective desensitization of the 5-HT4receptor-mediated response in pig atrium but not in stomach

(2009) JH De Maeyer et al.   BRITISH JOURNAL OF PHARMACOLOGY

Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation - a 12-week, randomized, double-blind, placebo-controlled study

(2008) E. M. M. QUIGLEY et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Treatment of Chronic Constipation: Current Pharmacologic Approaches and Future Directions

(2008) Jan Tack et al.   Clinical Gastroenterology and Hepatology

Renzapride: a new drug for the treatment of constipation in the irritable bowel syndrome

(2008) Emidio Scarpellini et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

T1418 Cardiovascular Safety of Prucalopride (Resolor®) in Healthy Subjects: Results from a Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial

(2008) Malcolm J. Boyce et al.   GASTROENTEROLOGY

Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives

(2008) J Tack et al.   GUT

Functional gastrointestinal disorders as a public health problem

(2008) n. j. talley   NEUROGASTROENTEROLOGY AND MOTILITY

A Placebo-Controlled Trial of Prucalopride for Severe Chronic Constipation

(2008) Michael Camilleri et al.   NEW ENGLAND JOURNAL OF MEDICINE